Incyte (INCY) Total Debt Growth (1y) (2016 - 2026)
Incyte (INCY) Total Debt Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | 103.99% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 3.84% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | Incyte | 23.72 Bn | 19.71 Bn | 1.17 Bn | -5.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.59% |
| Dec 31, 2025 | 4.86% |
| Sep 30, 2025 | 13.11% |
| Jun 30, 2025 | 26.07% |
| Mar 31, 2025 | 12.26% |
| Dec 31, 2024 | 2.12% |
| Sep 30, 2024 | 9.56% |
| Jun 30, 2024 | -0.94% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | 5.16% |
| Sep 30, 2023 | 7.69% |
| Jun 30, 2023 | 1.61% |
| Mar 31, 2023 | -1.86% |
| Dec 31, 2022 | -1.26% |
| Sep 30, 2022 | -10.55% |
| Jun 30, 2022 | -7.68% |
| Mar 31, 2022 | -5.09% |
| Dec 31, 2021 | -3.63% |
| Sep 30, 2021 | 221.17% |
| Jun 30, 2021 | 6.60% |